New anti-inflammation drug may lower heart disease and cancer risks

August 28, 2017

A drug that fights inflammation can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another, a new study finds.

heartmonitoring.jpg

Image courtesy of the New York Times.

Researchers outside the study say the findings represent a major milestone — proof of a biologic concept that opens the door to new ways of treating and preventing cardiovascular disease in people who are still at risk despite standard therapies.

But experts also cautioned that potentially fatal side effects of the drug, as well as its high cost, mean it is unlikely to be widely used. Cardiovascular disease is the leading cause of death worldwide and in the United States, where it killed nearly 634,000 people in 2015. Globally, it killed 15 million."


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Well Done, Wake!
Get Up, Stand Up, Stand Up for your...Heart
Pets Improve Your Health. Science Says So!

Featured Articles

AFFORDABLE HEALTHCARE SCORECARD ALERT – Protection Against Surprise Billing
AFFORDABLE HEALTHCARE SCORECARD ALERT – Transparency and Surprise Billing
AFFORDABLE HEALTHCARE SCORECARD ALERT – Removing Government Barrier to Better Care
Surprise Billing Legislation Introduced at NC General Assembly
New Study: Limiting Private Insurance Reimbursement to Medicare Rates would save $350 Billion a Year
Independent Commission Recommends Against Telehealth Mandates